Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges

Roche CEO: Future of cancer treatment, AI in ...

Up next

Friday Wrap-Up: Online Dating and the Portfolio Manager Debrief

This week’s Friday Wrap-Up looks at Nicolai Tangen’s podcast conversation with Spencer Rascoff, CEO of Match Group, the company behind dating apps like Tinder and Hinge. With Marthe Skaar in Oslo and Nicolai in London, they discuss how online dating has changed the way people mee ...  Show more

Match Group CEO: Digital Dating, What Makes a Good Profile and the Loneliness Epidemic

What actually makes two strangers match? Nicolai Tangen is joined by Spencer Rascoff, CEO of Match Group, the company behind Tinder, Hinge and a dozen other dating apps, for a conversation about how modern romance really works. They get into the algorithm doing the matchmaking, w ...  Show more

Recommended Episodes

The Challenges of Bringing AI into the Pharmaceutical Industry - with Kristof Szalay of Turbine.AI
The AI in Business Podcast

Today's guest is the great and brilliant Dr. Kristof Szalay, CTO and Founder of Turbine.AI. Turbine's AI-driven platform understands cancer's inner mechanisms, enabling the discovery of novel targets & precision medicinal therapies. Episode topics include: dynamics of pharmaceuti ...  Show more

AI, vaccine distrust, and the future of healthcare: Novartis CEO
Power Players with Brian Sozzi

Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian Sozzi talks at length with Novartis CEO Vas Narasimhan. Narasimhan has led the drug giant since 2018, doing deals that have expanded the company’s pipeline i ...  Show more

Billionaire Naveen Jain Reveals How AI Will Change Medicine Forever | EP #121
Moonshots with Peter Diamandis

In this episode, Peter and Naveen discuss the future of healthcare, how AI will revolutionize our health, and how to raise Moonshot kids.    Recorded on July 22nd, 2024 Views are my own thoughts, not Financial, Medical, or Legal Advice. 05:04 | The Cost of Chronic Diseases 38 ...  Show more

JP Morgan Healthcare Conference Highlights
Motley Fool Hidden Gems Investing

Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. Deidre Woollard caught up with Motley Fool biotech analyst Karl Thiel to discuss: - Biogen’s next shot at an Alzheimer’s treatment. - Why companies can’t “muscle their way” i ...  Show more